Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) - Total Liabilities

Latest as of March 2026: CN¥347.84 Million CNY ≈ $50.90 Million USD

Based on the latest financial reports, Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has total liabilities worth CN¥347.84 Million CNY (≈ $50.90 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 002932 year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A - Total Liabilities Trend (2011–2025)

This chart illustrates how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Wuhan Easy Diagnosis Biomedicine Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Competitors by Total Liabilities

The table below lists competitors of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A ranked by their total liabilities.

Company	Country	Total Liabilities
Union Optech Co Ltd SHE:300691	China	CN¥1.38 Billion
Guangdong Fangyuan Environment Co. Ltd. A SHG:688148	China	CN¥2.43 Billion
Compagnie du Bois Sauvage SA BR:COMB	Belgium	€186.49 Million
HANA Micron Inc KQ:067310	Korea	₩1.42 Trillion
YLZ Information Tech Co SHE:300096	China	CN¥478.84 Million
Hunan Hansen Pharmaceutical Co Ltd SHE:002412	China	CN¥310.49 Million
Chrysos Corporation Ltd AU:C79	Australia	AU$87.85 Million
Shandong Chenming Paper Holdings Ltd SHE:000488	China	CN¥48.86 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Wuhan Easy Diagnosis Biomedicine Co Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	18.35	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2025)

The table below shows the annual total liabilities of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥324.56 Million ≈ $47.49 Million	-43.50%
2024-12-31	CN¥574.40 Million ≈ $84.05 Million	-47.52%
2023-12-31	CN¥1.09 Billion ≈ $160.16 Million	-54.76%
2022-12-31	CN¥2.42 Billion ≈ $353.99 Million	+326.64%
2021-12-31	CN¥567.02 Million ≈ $82.97 Million	+81.87%
2020-12-31	CN¥311.77 Million ≈ $45.62 Million	+1267.39%
2019-12-31	CN¥22.80 Million ≈ $3.34 Million	-7.14%
2018-12-31	CN¥24.55 Million ≈ $3.59 Million	+80.49%
2017-12-31	CN¥13.60 Million ≈ $1.99 Million	-38.35%
2016-12-31	CN¥22.07 Million ≈ $3.23 Million	+18.84%
2015-12-31	CN¥18.57 Million ≈ $2.72 Million	+62.54%
2014-12-31	CN¥11.42 Million ≈ $1.67 Million	+12.05%
2013-12-31	CN¥10.19 Million ≈ $1.49 Million	+215.27%
2012-12-31	CN¥3.23 Million ≈ $473.19K	+67.03%
2011-12-31	CN¥1.94 Million ≈ $283.30K	--

About Wuhan Easy Diagnosis Biomedicine Co Ltd Class A

SHE:002932 China Medical Devices

Market Cap

$497.11 Million

CN¥3.40 Billion CNY

Market Cap Rank

#12054 Global

#3427 in China

Share Price

CN¥14.61

Change (1 day)

+1.95%

52-Week Range

CN¥13.85 - CN¥22.86

All Time High

CN¥49.58